The effects of Antidepressant Therapy on Health-Related Quality of Life in Patients with a Chronic Obstructive Pulmonary Disease and Depressive Symptoms

1. WHO. Chronic obstructive pulmonary disease (COPD). Available at https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd) Published June 21, 2021. Accessed: July 24, 2021. WHO Chronic obstructive pulmonary disease (COPD) Available at https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd) Published June 21, 2021. Accessed: July 24, 2021. Search in Google Scholar

2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease: 2021 Report. Available https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf. Accessed: July 26, 2021. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease: 2021 Report Available https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf. Accessed: July 26, 2021. Search in Google Scholar

3. Lazic Z, Stankovic I, Milenkovic B, Zvezdin B, Hromis S, Jankovic S, et al. Characteristics of COPD Phenotypes in Serbia. Int J Chron Obstruct Pulmon Dis. 2021;16:643–54. LazicZ StankovicI MilenkovicB ZvezdinB HromisS JankovicS Characteristics of COPD Phenotypes in Serbia Int J Chron Obstruct Pulmon Dis 2021 16 643 54 Search in Google Scholar

4. Nagorni-Obradovic LM, Vukovic DS. The prevalence of COPD co-morbidities in Serbia: results of a national survey. NPJ Prim Care Respir Med. 2014;24:14008. Nagorni-ObradovicLM VukovicDS The prevalence of COPD co-morbidities in Serbia: results of a national survey NPJ Prim Care Respir Med 2014 24 14008 Search in Google Scholar

5. Vukoja M, Kopitovic I, Lazic, Z, Milenkovic B, Stankovic I, Zvezdin B et al. Diagnosis and management of chronic obstructive pulmonary disease in Serbia: an expert group position statement. Int J Chron Obstruct Pulmon Dis. 2019;14:1993–2002. VukojaM KopitovicI LazicZ MilenkovicB StankovicI ZvezdinB Diagnosis and management of chronic obstructive pulmonary disease in Serbia: an expert group position statement Int J Chron Obstruct Pulmon Dis 2019 14 1993 2002 Search in Google Scholar

6. Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, et al; Committee on Nonsmoking COPD, Environmental and Occupational Health Assembly. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182(5):693–718. EisnerMD AnthonisenN CoultasD KuenzliN Perez-PadillaR PostmaD Committee on Nonsmoking COPD, Environmental and Occupational Health Assembly An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease Am J Respir Crit Care Med 2010 182 5 693 718 Search in Google Scholar

7. Montserrat-Capdevila J, Godoy P, Marsal JR, Barbé F, Galván L. Risk of exacerbation in chronic obstructive pulmonary disease: a primary care retrospective cohort study BMC Family Practice. 2015;16:173. Montserrat-CapdevilaJ GodoyP MarsalJR BarbéF GalvánL Risk of exacerbation in chronic obstructive pulmonary disease: a primary care retrospective cohort study BMC Family Practice 2015 16 173 Search in Google Scholar

8. Matte DL, Pizzichini MM, Hoepers AT, Diaz AP, Karloh M, Dias M, et al. Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies. Respir Med. 2016;117:154–61. MatteDL PizzichiniMM HoepersAT DiazAP KarlohM DiasM Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies Respir Med 2016 117 154 61 Search in Google Scholar

9. von Haehling S, Anker SD. Cachexia as major underestimated unmet medical need: facts and numbers. Int J Cardiol. 2012;161(3):121–3. von HaehlingS AnkerSD Cachexia as major underestimated unmet medical need: facts and numbers Int J Cardiol 2012 161 3 121 3 Search in Google Scholar

10. Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis. 1993;147(5):1151–6. ScholsAM SoetersPB DingemansAM MostertR FrantzenPJ WoutersEF Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation Am Rev Respir Dis 1993 147 5 1151 6 Search in Google Scholar

11. Blakemore A, Dickens C, Guthrie E, Bower P, Kontopantelis E, Afzal C, et al. Depression and anxiety predict health-related quality of life in chronic obstructive pulmonary disease: systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2014;9:501–12. BlakemoreA DickensC GuthrieE BowerP KontopantelisE AfzalC Depression and anxiety predict health-related quality of life in chronic obstructive pulmonary disease: systematic review and meta-analysis Int J Chron Obstruct Pulmon Dis 2014 9 501 12 Search in Google Scholar

12. Sundh J, Ekström M. Persistent disabling breathlessness in chronic obstructive pulmonary disease. Int J COPD. 2016;11(1):2805–12. SundhJ EkströmM Persistent disabling breathlessness in chronic obstructive pulmonary disease Int J COPD 2016 11 1 2805 12 Search in Google Scholar

13. Regvat J, Žmitek A, Vegnuti M, Košnik M, Šuškovič S. Anxiety and depression during hospital treatment of exacerbation of chronic obstructive pulmonary disease. J Int Med Res. 2011;39(3):1028–38. RegvatJ ŽmitekA VegnutiM KošnikM ŠuškovičS Anxiety and depression during hospital treatment of exacerbation of chronic obstructive pulmonary disease J Int Med Res 2011 39 3 1028 38 Search in Google Scholar

14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56–62. HamiltonM A rating scale for depression J Neurol Neurosurg Psychiatry 1960 23 1 56 62 Search in Google Scholar

15. Trajković G, Starčević V, Latas M, Leštarević M, Ille T, Bukumirić Z, et al. Reliability of the Hamilton Rating Scale for Depression: A meta-analysis over a period of 49 years. Psychiatry Research, 2011;189(1): 1–9. TrajkovićG StarčevićV LatasM LeštarevićM IlleT BukumirićZ Reliability of the Hamilton Rating Scale for Depression: A meta-analysis over a period of 49 years Psychiatry Research 2011 189 1 1 9 Search in Google Scholar

16. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: A New Measure. Psychopharmacology Bulletin 1993;29:321–6. EndicottJ NeeJ HarrisonW BlumenthalR Quality of Life Enjoyment and Satisfaction Questionnaire: A New Measure Psychopharmacology Bulletin 1993 29 321 6 Search in Google Scholar

17. Contoli M, Solidoro P, Di Marco F, Scichilone N, Corsico A, Braido F, et al. Effects of aclidinium on determinants of COPD severity: symptoms and quality of life. Int J Chron Obstruct Pulmon Dis. 2016;11:30 43–50. ContoliM SolidoroP Di MarcoF ScichiloneN CorsicoA BraidoF Effects of aclidinium on determinants of COPD severity: symptoms and quality of life Int J Chron Obstruct Pulmon Dis 2016 11 30 43 50 Search in Google Scholar

18. Khan A, Brodhead AE, Kolts RL, Brown WA. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials. J Psychiatr Res. 2005;39(2):145–50. KhanA BrodheadAE KoltsRL BrownWA Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials J Psychiatr Res 2005 39 2 145 50 Search in Google Scholar

19. Wiles NJ, Mulligan J, Peters TJ, Cowen PJ, Mason V, Nutt D, et al. Severity of depression and response to antidepressants: GENPOD randomised controlled trial. Br J Psychiatry. 2012;200(2):130–6. WilesNJ MulliganJ PetersTJ CowenPJ MasonV NuttD Severity of depression and response to antidepressants: GENPOD randomised controlled trial Br J Psychiatry 2012 200 2 130 6 Search in Google Scholar

20. Rogliani P, Ora J, Puxeddu E, Matera MG, Cazzola M. Adherence to COPD treatment: Myth and reality. Respir Med. 2017;129:117–23. RoglianiP OraJ PuxedduE MateraMG CazzolaM Adherence to COPD treatment: Myth and reality Respir Med 2017 129 117 23 Search in Google Scholar

21. Fan VS, Giardino ND, Blough DK, Kaplan RM, Ramsey SD; Nett Research Group. Costs of pulmonary rehabilitation and predictors of adherence in the National Emphysema Treatment Trial. COPD. 2008;5(2):105–16. FanVS GiardinoND BloughDK KaplanRM RamseySD Nett Research Group Costs of pulmonary rehabilitation and predictors of adherence in the National Emphysema Treatment Trial COPD 2008 5 2 105 16 Search in Google Scholar